SkinCeuticals, CeraVe, La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States
An annual Team Science Award will be Issued to Researchers Studying Artificial Intelligence (AI)...
Read MoreAn annual Team Science Award will be Issued to Researchers Studying Artificial Intelligence (AI)...
Read MoreNovartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E...
Read MoreMichigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule drug compound...
Read MoreWhile skin cancer remains a growing major public health problem, a recent study focusing instead on the disease’s economic impact miscommunicates those treatment costs relative to the price tag of (more…)
Read MoreAsking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by (more…)
Read MoreRecurrence of melanoma 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study,...
Read MoreCoco Chanel is often accredited with making the sun tan popular in the 1920s. Prior to that, having tanned skinned signified that you were a labourer or outdoor worker, thus signifying...
Read More